Because the world faces rising way of life ailments, environmental degradation and social fragmentation, there’s a rising recognition that we have to restore stability between folks and planet, progress and sustainability, innovation and instinct.
Well being in its truest sense is all the time a mirrored image of the concord inside the human physique and between people and nature. It is a core precept of conventional medical techniques around the globe, which view well being not merely because the absence of illness, however because the existence of a state of equilibrium. So the science of happiness isn’t new. It’s a rediscovery of conventional understandings, now reaffirmed via evidence-based analysis.
The World Well being Group (WHO) experiences that roughly 90% of WHO member nations report using conventional medication. It stays a first-line remedy for billions of individuals, particularly in low- and middle-income nations the place accessibility and affordability are paramount.
However its worth goes far past well being care. Conventional medication helps biodiversity, diet, meals safety, and livelihoods and embodies the holistic idea of integrative well being. Market analysts peg India’s AYUSH sector at $43.4 billion, however this quantity tells an even bigger story. This surge is pushed not solely by shopper preferences but in addition by a paradigm shift. Healthcare techniques are evolving from a reactive mannequin of care to a mannequin of proactive, customized care. This world shift represents a typical recognition that happiness can’t be achieved via a piecemeal strategy. It requires a balanced ecosystem between thoughts and physique, people and atmosphere, science and spirit. It’s a indisputable fact that India has emerged as a hub of progressive analysis and growth initiatives which might be remodeling the standard medication sector globally.
To assist this transformation, WHO’s World Conventional Drugs Middle (GTMC) serves as a data hub for evidence-based collaboration and innovation. GTMC goals to optimize the contribution of conventional medication to world well being and sustainable growth, with a strategic concentrate on proof and studying, information and evaluation, sustainability and fairness. We additionally assist basic rules which might be typically missed within the age of globalization: respect for native traditions, assets and rights.
Established in Jamnagar, Gujarat with basic assist from the Authorities of India, GTMC is an expression of shared world management. This displays WHO’s imaginative and prescient that harnessing the potential of conventional medication, based mostly on scientific proof, innovation and sustainability, can rework well being.
India’s dedication to this imaginative and prescient stems from the idea that data should serve humanity as a complete. The institution of the middle in India is a testomony to this spirit.
The Prime Minister’s emphasis on evidence-based analysis on this discipline has paved the way in which for wider world acceptance of Indian conventional medication, with initiatives such because the institution of a devoted AYUSH unit on the Bureau of Indian Requirements (BIS) and the event of a worldwide customary for AYUSH techniques via the ISO/TC 249/SC 2 subcommittee.
The rising recognition of conventional medication as a scientific and social asset took a decisive step with the primary WHO World Summit on Conventional Drugs held in August 2023 in Gandhinagar, Gujarat, in parallel with the G-20 Well being Ministers’ Assembly. Bringing collectively ministers, scientists, specialists, and communities from around the globe, it mobilized political engagement, fostered data-driven motion, and laid the inspiration for the evidence-based integration of conventional medication into nationwide well being techniques. The Gujarat Declaration adopted on the summit referred to as for biodiversity conservation, equitable profit sharing, digital innovation, and equal entry to conventional well being data.
The worldwide group is now able to take the subsequent step in deepening scientific understanding, fostering innovation, and aligning the potential of conventional medication with trendy world well being priorities. WHO and the Authorities of India have subsequently signed a Memorandum of Understanding to co-host the 2nd WHO Conventional Drugs Summit (New Delhi, 17-19 December 2025), marking a brand new chapter in world cooperation for well being and sustainability. Mobilize multi-stakeholder motion in assist of WHO’s new 10-year World Conventional Drugs Technique (2025-34), adopted on the 78th World Well being Meeting earlier this yr, with the theme ‘Restoring stability: the science and follow of well being and well-being’.
These initiatives purpose not solely to rejoice the custom of conventional medication, but in addition to propel it right into a future the place it’s validated by science, enhanced by know-how, and guided by ethics. Because the birthplace of Ayurveda, Yoga, Unani, Siddha and Sowa Rigpa, India’s contribution lies in demonstrating how conventional data can coexist with trendy science.
Its strategy is rooted in integration, bringing collectively custom and know-how, analysis and group engagement, well-being and sustainability. Because the world comes collectively once more in a typical willpower to revive stability, India’s message is straightforward however profound. Well being ought to be healed, not broken. Progress should be sustained, not consumed. And science ought to be useful, not separate.
The Summit is extra than simply an occasion, it’s a world gathering to reaffirm that the way forward for well being lies in concord.
Prataprao Jadhav is Union Minister of State (Impartial Cost) for AYUSH and Minister of State for Well being and Household Welfare, Authorities of India.
issued – November 24, 2025 12:32am IST
